Trust Collapsing. It’s Time to Rebuild FDA Transparency
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
Index funds win long term largely because of lower costs and broad diversification. This brief introduces the cost advantage and payoff.
27,987 articlesTrust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
This analysis unpacks Interface (Tile)'s Q4 2025 earnings, translating numbers into a practical view for investors. L...
Anthropic faces a high-stakes clash with the Pentagon while preparing for a potential IPO. The CFO's strategy will be...
Oil markets remain volatile amid geopolitical risk, but three U.S. majors are drawing attention for potential 50%+ re...
Circle’s ARC presale unlocks a $3 billion fully diluted valuation and signals a broader push into institutional finan...
Citi Trends operates in a competitive discount fashion space where every dollar of margin and every promotional beat ...
A hidden Medicare surcharge, IRMAA, can lift monthly premiums from $202.90 to as high as $689.90. Experts say the cha...
With American Express set to report on July 24, analysts say a durable franchise, disciplined capital returns, and a ...
A leading economist argues that the stock market has drifted away from the pace of everyday economic activity as grow...
China unveils a restrained 2026 growth target of 4.5% to 5%, marking the lowest goal in decades as policymakers weigh...
AI’s endless appetite for compute and memory is shifting demand away from PCs. Prices rise, supply tightens, and inve...
A growing number of newlyweds confront the mine-vs.-ours debt question as one partner considers wiping out the $28,00...